 | Up a level |
Ciurea, Adrian; Kissling, Seraphina; Bürki, Kristina; Baraliakos, Xenofon; de Hooge, Manouk; Hebeisen, Monika; Papagiannoulis, Eleftherios; Exer, Pascale; Bräm, René; Nissen, Michael J; Möller, Burkhard; Kyburz, Diego; Andor, Michael; Distler, Oliver; Scherer, Almut; Micheroli, Raphael (2022). Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort. RMD open, 8(1), e002067. BMJ Publishing Group 10.1136/rmdopen-2021-002067
Ciurea, Adrian; Papagiannoulis, Eleftherios; Bürki, Kristina; von Loga, Isabell; Micheroli, Raphael; Möller, Burkhard; Rubbert-Roth, Andrea; Andor, Michael; Bräm, René; Müller, Angela; Dan, Diana; Kyburz, Diego; Distler, Oliver; Scherer, Almut; Finckh, Axel (2021). Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the rheumatic diseases, 80(2), pp. 238-241. BMJ Publishing Group 10.1136/annrheumdis-2020-218705
Micheroli, Raphael; Tellenbach, Christoph; Scherer, Almut; Bürki, Kristina; Niederman, Karin; Nissen, Michael J; Zufferey, Pascal; Exer, Pascale; Möller, Burkhard; Kyburz, Diego; Ciurea, Adrian (2020). Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort. Annals of the rheumatic diseases, 79(9), pp. 1203-1209. BMJ Publishing Group 10.1136/annrheumdis-2019-215934
Hebeisen, Monika; Micheroli, Raphael; Scherer, Almut; Baraliakos, Xenofon; de Hooge, Manouk; van der Heijde, Désirée; Landewé, Robert; Bürki, Kristina; Nissen, Michael J; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2020). Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort. PLoS ONE, 15(3), e0230268. Public Library of Science 10.1371/journal.pone.0230268
Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J; Tamborrini, Giorgio; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2019). Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLoS ONE, 14(5), e0216746. Public Library of Science 10.1371/journal.pone.0216746
